BioCentury
ARTICLE | Clinical News

TL-118: Phase II started

February 20, 2012 8:00 AM UTC

Tiltan began an open-label, Israeli Phase II trial to compare oral TL-118 once daily plus gemcitabine vs. gemcitabine alone in 80 newly diagnosed patients. ...